Wang, Ya Xing
Pan, Zhe
Xue, Can Can
Xie, Hui
Wu, Xiaodong
Jonas, Jost B.
Funding for this research was provided by:
National Natural Science Foundation of China (81570835)
Beijing Municipal of Health Reform and Development Project (2019-4)
Article History
Received: 19 October 2022
Accepted: 30 March 2023
First Online: 3 April 2023
Competing interests
: Jost B. Jonas: European patent application 16 720 043.5 and US patent application US 2019 0085065 A1: Agents for use in the therapeutic or prophylactic treatment of myopia or hyperopia), remaining other author don’t have any competing interests.